20
Participants
Start Date
December 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
August 31, 2008
Technosphere Insulin
Technosphere® Insulin (TI) Inhalation Powder, prandial
M.E.R.I., New York
MODEL Clinical Research, Baltimore
Private Practice, Decatur
Endocrine Research Solutions, Inc., Roswell
Your Diabetes Endocrine Nutrition Group, Mentor
Rapid Medical Research Inc, Cleveland
Billings Clinic Research Division, Billings
Cedar-Crosse Research Center, Chicago
Healthcare Research, Florissant
Diabetes & Glandular Disease Research Assoc PA, San Antonio
Magna Center for Family Medicine, Magna
Arizona Research Associates, Tuscon
New Mexico Clinical Research & Osteoporosis Center, Albuquerque
Diabetes/Lipid Management and Research Center, Huntington Beach
FSI Principal Military Clinical Hospital n.a. academician N.N. Burdenko of the Ministry of Defense, Moscow
Russian State Medical University City Hospital # 4, Moscow
RAAMS Endocrinology and Diabetology Department, Moscow
Clinical Pharm Dept of Yaroslavl Clin Hospital, Yaroslavl
NHI Yaroslavl Regional Clinical Hospital, Yaroslavl
Yaroslavl Regional Clinical Hospital, Yaroslavl
Kemerovo State Medical Academy of Ministry of Health, Kemerovo
NHI Kemerovo Regional Clinical Hospital, Kemerovo
Valley Research (Norwood), Fresno
Parkwood Hospital, London
Lead Sponsor
Mannkind Corporation
INDUSTRY